You just read:

ProNAi Therapeutics Granted Orphan Drug Designation for PNT2258 for the Treatment of Diffuse Large B-Cell Lymphoma

News provided by

ProNAi Therapeutics Inc.

Mar 14, 2016, 07:00 ET